dr peter attia semaglutide Could GLP-1s impact aging and cognitive health? 246 - AMA #45: Pros

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Conditions That May Defer Blood Donation While on GLP-1 Therapy Blood banks may defer donors with poorly controlled diabetes, regardless of whether they take GLP-1 medications

However, the results are promising

This was done in an effort to assess only peptides most likely to constitute components of true biological changes attributable to treatment

This objective data helps establish a safety baseline and provides a reference point for monitoring changes during treatment

Our all-female provider team works closely with each patient to make sure they feel informed, respected, and cared for at every step